West Lafayette, IN, United States of America

Stephan Xander Mattheus Boerrigter

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 8.3

ph-index = 5

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovations of Stephan Xander Mattheus Boerrigter

Introduction

Stephan Xander Mattheus Boerrigter is an esteemed inventor based in West Lafayette, Indiana. With a remarkable portfolio of 11 patents, his contributions to the field have made a significant impact, particularly in the pharmaceutical sector.

Latest Patents

Among his latest innovations are patents related to glycopyrrolate salts. These patents disclose various solid forms and formulations, including topicals, and elaborate on methods of making these salts. Furthermore, they address treatment methods for hyperhidrosis using glycopyrrolate salts and their topical formulations. This innovative work showcases his commitment to advancing medical treatments and improving patient care.

Career Highlights

Stephan has made notable strides in his career by working with prominent companies such as Dermira, Inc. and Journey Medical Corporation. His roles in these organizations have enabled him to drive forward his innovative ideas and execute impactful research.

Collaborations

Throughout his career, Stephan has collaborated with esteemed colleagues, including John Allan Statler and Anthony Adrian Shaw. Their teamwork exemplifies the power of collaboration in enhancing the effectiveness and reach of inventive endeavors.

Conclusion

Stephan Xander Mattheus Boerrigter stands out as a leading figure in the realm of innovation, particularly in his work on glycopyrrolate salts. His dedication to advancing healthcare through his patents not only highlights his skills as an inventor but also underlines the importance of teamwork in achieving groundbreaking advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…